It has been proven that upregulation of miR-329 suppresses CRC cell invasion by inhibiting TGF-β1, and low expression of miR-329 is correlated with lymph node metastasis in CRC patients [191]. Here, TGFB1 is linked to metastatic malignant neoplasm in the lymph nodes.